Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.29T, Eli Lilly(LLY) trades at $1,361.50. The stock has a price-to-earnings ratio of 46.59 and currently yields dividends of 0.47%.
During the trading session on 2026-11-05, Eli Lilly(LLY) shares reached a daily high of $1,453.00 and a low of $1,360.00. At a current price of $1,361.50, the stock is +0.1% higher than the low and still -6.3% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 4.76M, versus its average volume of 3.29M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,453.00 and a low of $850.51.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,453.00 and a low of $850.51.
LLY News
Eli Lilly (NYSE: LLY) agreed a clinical trial collaboration with Zenith Epigenetics to study ZEN-3694 and Verzenio in NUT carcinoma. The business launched a Li...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly’s Phase 1 study, titled “A Phase 1, Open-Label, 4-Pa...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is a collaborator in NCT05002127, offici...
Analyst ratings
85%
of 33 ratingsMore LLY News
Eli Lilly just crushed earnings and raised guidance, yet the most compelling part of its story has almost nothing to do with what already happened. The real que...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company (LLY) is studying whether EloraTZP can s...
Eli Lilly (NYSE: LLY) pursued US$18.2b of acquisitions in 2026 aimed at reshaping its R&D pipeline beyond obesity treatments. New oncology data on first-line K...
Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates. The Danish weight-loss drug maker is look...
...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is studying LY3867070 in healthy partici...
Eli Lilly's weight-loss drugs get all the headlines, but CEO David Ricks is betting the company's next act looks nothing like its last one. Here is what it woul...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.